FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Johnson & Johnson Reports Five-Year Survival Rate of 69.2%

      Johnson & Johnson has announced a five-year overall survival rate of 69.2% for patients in its latest clinical study. The company also reported a median progression-free survival of 60.5 months, indicating a significant period during which patients experienced no disease progression.

      These findings highlight the effectiveness of Johnson & Johnson's treatment protocols, contributing to ongoing discussions about advancements in patient care and treatment outcomes in the healthcare sector. The results are expected to influence future research and development strategies within the pharmaceutical industry.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud